⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12734931 | 0.92 | DNM1 (0.41) | — | |
| SCHEMBL24444340 | 0.89 | DNM1 (0.46) | — | |
| SCHEMBL11947283 | 0.89 | DNM1 (0.46) | — | |
| SCHEMBL48727 | 0.84 | CYP2D6 (0.41) | — | |
| SCHEMBL24541036 | 0.83 | CYP2D6 (0.32) | — | |
| SCHEMBL2374634 | 0.81 | — | — | |
| Hexadecylamine SCHEMBL9800669 | 0.81 | DNM1 (0.61) | — | |
| SCHEMBL27160388 | 0.81 | TDP1 (0.40) | — | |
| SCHEMBL22104762 | 0.80 | DNM1 (0.41) | — | |
| SCHEMBL19987637 | 0.80 | DNM1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2997133-B1 | METHODS FOR ENGINEERING HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPY | CELLECTIS (FR) | 2023-08-23 | — | — | EP | disclosed |
| WO-2020232439-A1 | METHODS AND MATERIALS FOR TREATING CANCER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2020-11-19 | — | — | WO | disclosed |
| EP-3129392-B1 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY, SUBSTITUTED IN POSITION 3 BY A NON-AROMATIC RING CARRYING A HALOALKYL SUBSTITUENT | VIIV HEALTHCARE UK NO 4 LTD (GB) | 2020-08-05 | — | — | EP | disclosed |
| WO-2017019833-A1 | COMPOSITIONS CONTAINING REPAIR CELLS AND CATIONIC DYES | MEDIVATION TECHNOLOGIES, INC. (US) | 2017-02-02 | — | — | WO | disclosed |
| US-8569420-B2 | Singly-terminated polyisobutylenes and process for making same | THE UNIVERSITY OF AKRON (US) | 2013-10-29 | — | — | US | disclosed |
| US-8552118-B2 | Polyisobutylenes and process for making same | THE UNIVERSITY OF AKRON (US) | 2013-10-08 | — | — | US | disclosed |
| US-20110082259-A1 | SINGLY-TERMINATED POLYISOBUTYLENES AND PROCESS FOR MAKING SAME | THE UNIVERSITY OF AKRON (US) | 2011-04-07 | — | — | US | disclosed |
| US-20100130696-A1 | POLYISOBUTYLENES AND PROCESS FOR MAKING SAME | THE UNIVERSITY OF AKRON (US) | 2010-05-27 | — | — | US | disclosed |
| EP-1689359-A2 | COMPOSITION FOR THE TREATMENT OF ARTHROSIS/ARTHRITIS, ESPECIALLY FOR TREATING JOINTS | Trott, Katharina (DE) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005039528-A2 | COMPOSITION FOR THE TREATMENT OF ARTHROSIS/ARTHRITIS, ESPECIALLY FOR TREATING JOINTS | BESCHORNER KATHARINA (DE) | 2005-05-06 | — | — | WO | disclosed |
| US-5684029-A | HYPOTENSIVE AGENTS | KARL THOMAE GMBH (DE) | 1997-11-04 | — | — | US | disclosed |
| US-5614519-A | (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists | KARL THOMAE GMBH (DE) | 1997-03-25 | — | — | US | disclosed |
| US-5602127-A | ADMINISTERING TO TREAT HYPERTENSION | KARL THOMAE GMBH (DE) | 1997-02-11 | — | — | US | disclosed |
| US-5594003-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-14 | — | — | US | disclosed |
| US-5591762-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-07 | — | — | US | disclosed |
| US-5587393-A | ANGIOTENSIN ANTAGONIST USEFUL IN TREATING HYPERTENSION | DR. KARL THOMAE GMBH (DE) | 1996-12-24 | — | — | US | disclosed |
| US-5385925-A | Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them | DR. KARL THOMAE GMBH (DE) | 1995-01-31 | — | — | US | disclosed |